Skip to Content
Learn about Adcetris a treatment of Hodgkin Lymphoma

Bexarotene topical Pregnancy and Breastfeeding Warnings

Bexarotene topical is also known as: Targretin Gel

Medically reviewed on August 6, 2018

Bexarotene topical Pregnancy Warnings

Bexarotene topical has been assigned to pregnancy category X by the FDA. Animal studies have revealed evidence of malformations. There are no controlled data in human pregnancy. Bexarotene topical is considered contraindicated during pregnancy.

See references

Bexarotene topical Breastfeeding Warnings

There are no data on the excretion of bexarotene topical into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Targretin (bexarotene topical)" Stiefel Laboratories Inc, Coral Gables, FL.
  2. "Product Information. Targretin (bexarotene)" Ligand Pharmaceuticals, San Diego, CA.

References for breastfeeding information

  1. "Product Information. Targretin (bexarotene topical)" Stiefel Laboratories Inc, Coral Gables, FL.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide